Improving outcomes for patients with failed sleeve gastrectomy using a new surgical approach

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of the Single-Anastomosis Duodenoileal Switch (SADI-S) as a revisional surgery for patients who have experienced failure after sleeve gastrectomy. The study aims to compare this newer, simplified surgical technique with the standard duodenal switch procedure. By focusing on patients who meet specific criteria related to their previous weight loss surgery, the trial seeks to provide evidence on the safety and efficacy of SADI-S in managing obesity. The goal is to address the significant rates of failure associated with sleeve gastrectomy and improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* had sleeve gastrectomy a minimum of 18 months before
* still meet the NIH criteria for bariatric surgery (BMI≥35kg/m2 with major comorbidities or BMI≥40kg/m2) or patients with EWL\<50% or significant weight regain (≥20%EWL)

Exclusion Criteria:

* general contra-indication for bariatric surgery
* BMI\<35kg/m2
* pregnancy
* cirrhosis
* abnormal bowel habits including irritable bowel syndrome and inflammatory bowel disease

Where it's running

• Institut Universitaire de Cardiologie et de Pneumologie de Québec
  Québec, Quebec, Canada Recruiting

Study contacts

• Principal investigator: Laurent Biertho, MD — Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
• Study coordinator: Mélanie Nadeau, MSc
• Email: melanie.nadeau@criucpq.ulaval.ca
• Phone: 418-656-8711

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endoscopic treatment for overweight and mild obesity using Orbera365

  This study is testing whether the Orbera365 intragastric balloon can help people who are overweight or mildly obese lose weight over a year.

  Recruiting Kaiser Clinic and Hospital · Santo André, São Paulo · NCT06785233

• Adding naltrexone–bupropion extended‑release to sleeve gastrectomy to improve weight loss

  This trial will test whether taking naltrexone–bupropion extended‑release after sleeve gastrectomy helps adults with obesity lose more weight and improve related health problems.

  Recruiting Phase 4 Laval University · Québec, Quebec · NCT06620562

• Using a new endoscopy technique for bariatric patients

  This study is testing a new, less invasive endoscopy method for bariatric patients to see if it can improve safety and reduce costs when checking for stomach and digestive issues.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06200961

• Endoscopic Antral Myotomy for Weight Loss

  This study is testing a new weight loss procedure called Pylorus Sparing Antral Myotomy to see if it helps people with obesity lose weight safely and effectively on its own.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT05711758

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.